(SINV (SINV (QT (DQL ``) (QTC (S (BASENP (DT This)) (VP (VBZ provides) (NP (BASENP (DT the) (NN basis)) (PP (IN for) (NP (BASENP (JJ future) (NNS studies)) (SBAR (WHNP (WDT that)) (S (VP (MD will) (VP (VB be) (VP (VBN designed) (S (VP (TO to) (VP (VB provide) (NP (NP (BASENP (DT a) (JJ detailed) (NN understanding)) (PP (IN of) (NP (BASENP (DT the) (NN interaction)) (PP (IN between) (NP (BASENP (NN PA-457)) (CC and) (BASENP (PRPD its) (NN target))))))) (CONJP (ADVP (RB as) (RB well)) (IN as)) (NP (BASENP (NNS insights)) (PP (IN into) (NP (BASENP (DT the) (NN design)) (PP (IN of) (NP (BASENP (JJ new) (NNS generations)) (PP (IN of) (BASENP (NN maturation) (NNS inhibitors)))))))))))))))))))))) (COMMA ,)) (DQR '')) (SINV (VP (VBD said)) (NP (NP (BASENP (NN CEO)) (PP (IN of) (BASENP (NNP Panacos) (NNPS Pharmaceuticals)))) (COMMA ,) (BASENP (NNP Graham) (NNP Allaway))))) (PERIOD .))